Daily EPS Performer Reports

Stocks detected early by our EPS revision screener — and how they performed.

2026-07-17
RCELCOTYRHBILLCVI

RCEL surges 26.9% on EPS revision; COTY, RH, BILL, CVI also gain

Five stocks detected by our EPS revision screener posted double-digit gains. AVITA Medical (RCEL) led with a 26.9% surge after its forward EPS growth estimate was raised to 48.4%, coinciding with its Q2 earnings announcement. Coty (COTY) gained 22.5% on a 60% EPS growth estimate and positive Gucci license news, while RH (RH) rose 15.6% with an 86.1% estimate upgrade. Bill Holdings (BILL) and CVR Energy (CVI) also saw strong moves on upward revisions of 26.4% and 5241.2%, respectively.

Read analysis →
2026-07-16
COTYRHBILLMBUUSFIX

EPS Revision Leaders: COTY, RH, BILL, MBUU, SFIX Surge 11-17% in Week

Stocks with upward EPS revisions outperformed this week. COTY jumped 16.9% after Gucci license resolution, RH gained 16.4% on upgrade, and BILL rose 13.6% in a tech rally. MBUU and SFIX also rallied on strong revision momentum.

Read analysis →
2026-07-15
RHONEWPTENSBETSHLS

RH Leads EPS Revision Rally with 17% Surge; Onewater and Patterson-UTI Also Jump

Today's top performers were led by RH, which surged 17.0% after a Goldman Sachs upgrade, and Onewater Marine, which gained 16.9% on a sharp EPS estimate revision. Patterson-UTI Energy rose 14.9% on a 30.8 percentage point EPS revision and analyst upgrade, while SharpLink and Shoals also posted double-digit gains on upward estimate changes.

Read analysis →
2026-07-14
ONEWPTENIQNETSBET

EPS Revision Screen Highlights: ONEW +16.6%, PTEN +15.2%, and NET +13.8%

Today's top EPS revision gainers include Onewater Marine (+16.6%), Patterson-UTI Energy (+15.2%), iQIYI (+14.8%), Cloudflare (+13.8%), and SharpLink (+11.8%). Each stock saw its forward EPS growth estimate raised significantly, with PTEN also benefiting from a Piper Sandler upgrade on improved U.S. land activity, and NET getting multiple price target hikes from analysts. The moves reflect strong market validation of earnings momentum.

Read analysis →
2026-07-13
PTENIQALTGONEWPDS

Top EPS Revision Gainers: PTEN, IQ, ALTG, ONEW, PDS Surge Up to 13.1%

Today's top performers from our EPS revision screener include PTEN (+13.1%), IQ (+11.9%), ALTG (+11.2%), ONEW (+10.9%), and PDS (+10.2%). These stocks all jumped after analysts raised their forward EPS growth estimates, with PTEN leading on a 30.8pp revision and an upcoming earnings call. The moves underscore market conviction in accelerating earnings across energy, industrials, and consumer cyclical sectors.

Read analysis →
2026-07-09
WBXBBIOHOODCNCKIQ

Top EPS Revision Gainers: WBX Surges 43.5%, BBIO +21.1% on Competitor Setback

Today's top performers were led by Wallbox (WBX) surging 43.5% from a detected EPS revision on June 30. BridgeBio (BBIO) gained 21.1% on a competitor trial failure and a $1B equity raise. Robinhood (HOOD) rose 14.8% despite market headwinds, while Coincheck (CNCK) and iQIYI (IQ) posted double-digit gains driven by upward EPS revisions.

Read analysis →
2026-07-08
WBXGSHDCNCKIOTVERX

WBX +34.8%, CNCK +18.0% Lead EPS Revision Movers on July 8

Stocks with upward EPS estimate revisions surged this week, with Wallbox (WBX) jumping 34.8% after its estimate rose 10.6 percentage points to 61.3% and Coincheck (CNCK) gaining 18.0% as its estimate edged up to 136.4%. Goosehead Insurance (GSHD), Samsara (IOT), and Vertex (VERX) each posted double-digit gains following analyst upgrades, highlighting strong momentum in both technology and financial sectors.

Read analysis →
2026-07-07
WBXRBRKMRNAVERXNMAX

WBX +40.8% Leads EPS Revision Winners; NMAX Surges on 217.8pp EPS Upgrade

Stocks with upward EPS estimate revisions delivered strong gains. WBX jumped 40.8% after analysts raised forward EPS growth from 50.6% to 61.3%, reinforced by an equity raise and Q2 results announcement. RBRK gained 20.3% on 106.4% EPS growth estimate, while MRNA rose 18.6% on 45.4% growth. VERX and NMAX also rallied 17.5% and 16.7% respectively, with NMAX seeing a staggering 217.8 percentage point EPS revision.

Read analysis →
2026-07-06
WBXIOTMRNANMAXRBRK

Stock Surge Alert: WBX +47%, IOT +29%, MRNA +22% on EPS Revisions

Five stocks detected by EPS revision screener rallied sharply after estimates were raised, led by Wallbox (WBX) surging 47.1% on a 10.6 percentage point upgrade. Samsara (IOT) gained 29.4% and Moderna (MRNA) rose 21.6%, while Newsmax (NMAX) and Rubrik (RBRK) each climbed 20.8%. The moves reflect strong market validation of upward earnings revisions across tech and healthcare.

Read analysis →
2026-07-02
QNRXIOTNMAXHNGEMRNA

Top Stock Gainers Driven by EPS Estimate Revisions: QNRX Up 40.9%, IOT Up 24% - July 2, 2026

On July 2, 2026, stocks that received upward EPS estimate revisions continued to outperform. QNRX surged 40.9% since detection on June 23, with its forward EPS growth estimate raised from 45.4% to 54.8%. IOT, NMAX, HNGE, and MRNA also posted gains between 18.6% and 24.0%, supported by sector momentum and positive earnings outlooks.

Read analysis →
2026-07-01
QNRXNTSKNMAXMRNABILL

Top EPS Revision-Driven Movers: QNRX Surges +44.9% as NMAX Sees 376.9% Growth Estimate

Strong EPS estimate revisions powered gains across Healthcare, Technology, and Communication Services stocks between June 22-28. QNRX led with a 44.9% jump after a 9.5pp revision to 54.8% EPS growth, while NMAX's 217.8pp revision to 376.9% drove a 25.1% rally. BILL added a CRO appointment to sustain its 21.3% gain.

Read analysis →
2026-06-30
QNRXHELPACMRCADLNTSK

QNRX surges 48.9% as EPS revision signal precedes price breakout; HELP, ACMR also climb

Today's top EPS revision plays were led by QNRX (+48.9%) and HELP (+41.5%), both healthcare names. QNRX jumped after analysts raised its forward EPS growth estimate by nearly 10 percentage points, while HELP's rally was reinforced by strong Phase 3 trial updates and a $50M offering. Technology stocks ACMR (+24.9%) and NTSK (+22.2%) also gained following upward estimate revisions.

Read analysis →
2026-06-29
LILALILAKHELPBDSXQNRX

EPS Revision Bonanza: LILA +61%, HELP +47%, BDSX +42% Lead Surge

The EPS revision screener detected massive upward estimate changes in LILA and LILAK, which subsequently rallied 61% and 59%, respectively, with no news catalysts. HELP gained 47% after its EPS estimate was raised and was further boosted by positive fiscal 2026 results. BDSX and QNRX also advanced 41-40% on modest but well-received revisions.

Read analysis →
2026-06-25
FTHCRMTLILALILAKHELP

FTH Surges 69.8% on EPS Revision; LILA, CRMT Also Jump

Faeth Therapeutics (FTH) led with a 69.8% gain after analysts revised its forward EPS growth estimate to 93.7% on June 16. Liberty Latin America (LILA) jumped 45.8% on a 131.8 percentage point upward revision, while CRMT gained 62.0% on a 101.7% EPS growth estimate. All moves occurred without direct earnings news, highlighting the market's confidence in the revised outlooks.

Read analysis →
2026-06-24
FTHCRMTLILALILAKRYTM

FTH Leads EPS Revision Rally with 68.9% Surge; CRMT, LILA Also Gain

Stocks flagged by our EPS revision screener surged in late June, led by Faeth Therapeutics (FTH) which jumped 68.9% from $14.53 to $24.54 after its forward EPS growth estimate was raised to 93.7%. Americas Car Mart (CRMT) gained 52.6% to $3.57 on a 101.7% growth estimate, while Liberty Latin America (LILA) rose 37.5% to $6.60 after a 131.8 percentage point revision. The moves occurred without specific earnings news, underscoring the power of estimate revisions in driving price.

Read analysis →
2026-06-23
FTHCRMTRFILLILALILAK

FTH +65%, CRMT +65% Lead EPS Revision Surge; RFIL +29%, LILA +24%

On June 23, FTH and CRMT each surged over 65% after upward EPS estimate revisions were detected on June 16. RFIL gained 28.5% following its Q2 earnings beat, while LILA and LILAK rose 24% and 22.8% respectively on massive estimate hikes.

Read analysis →
2026-06-22
OTLKFTHWDCRFILCRMT

Top EPS Revision Winners: OTLK Surges 66%, FTH Gains 60% on Estimate Hikes

Outlook Therapeutics (OTLK) jumped 66.4% after analysts raised its EPS growth estimate and the FDA accepted its BLA resubmission. Faeth Therapeutics (FTH) and Western Digital (WDC) also gained 59.6% and 38.4% respectively on EPS estimate upgrades and strong sector tailwinds. RF Industries (RFIL) and Americas Car Mart (CRMT) followed with gains of 30.8% and 28.6% on earnings beats and high growth expectations.

Read analysis →
2026-06-18
OTLKWDCFCELUCTTHOOD

OTLK Surges 43.6% on FDA News; WDC +41%, FCEL +37.5% Lead EPS Revision Movers

Outlook Therapeutics (OTLK) jumped 43.6% after an upward EPS revision (48.3%→53.0%) was reinforced by FDA acceptance of its BLA for wet AMD. Western Digital (WDC) gained 41.0% on a 76.4% EPS growth estimate and blockbuster earnings driven by AI/cloud demand. FuelCell Energy (FCEL), Ultra Clean Holdings (UCTT), and Robinhood (HOOD) also rallied after analysts raised estimates, with HOOD supported by record trading volumes and analyst upgrades.

Read analysis →
2026-06-17
OTLKWDCHOODSTXUCTT

Outlook Therapeutics Soars 50% as EPS Revision and FDA Acceptance Fuel Rally

Outlook Therapeutics (OTLK) surged 50% after an EPS revision from 48.3% to 53.0% and FDA acceptance of its BLA resubmission. Western Digital (WDC) jumped 34.5% on strong earnings driven by AI/cloud demand, while Robinhood (HOOD) rose 25.6% on analyst upgrades and record trading volumes. Seagate (STX) and Ultra Clean (UCTT) also posted double-digit gains following upward EPS revisions in the tech sector.

Read analysis →
2026-06-16
OTLKWDCBIOAONTOBFLY

OTLK, WDC Lead EPS Revision Winners: +42.7% and +33.1% Gains

OTLK surged 42.7% after its EPS growth estimate was revised to 53.0% and the FDA accepted its BLA resubmission for wet AMD. WDC climbed 33.1% on AI memory demand and a Mizuho price target hike. BIOA, ONTO, and BFLY also gained over 20% following upward EPS revisions.

Read analysis →
2026-06-15
ONTOWDCBIOACURVCRDO

ONTO, WDC Lead Surging Stocks on EPS Revisions; Gains Top 32%

Stocks detected by an EPS revision screener on June 7 have delivered strong gains. ONTO jumped 32.7%, WDC 27.7%, BIOA 26.4%, CURV 25.6%, and CRDO 25.4%, each benefiting from upward EPS revisions. WDC also saw a Mizuho price target boost on AI memory demand, while ONTO and CRDO rode tech sector momentum.

Read analysis →
2026-06-11
CMCTENHABFLYCRDOCAVA

CMCT Surges 43.9% on EPS Revision; ENHA, BFLY, CRDO, CAVA Follow

Stocks flagged by our EPS revision screener posted strong gains since detection. CMCT jumped 43.9% to $4.72 after EPS growth estimates hit 84.8%. ENHA gained 37.1% to $3.88 on a 140.4% EPS growth estimate. BFLY rose 24.3% to $5.68, CRDO climbed 23.4% to $264.76, and CAVA added 21.6% to $88.25 — all on upward estimate revisions and reinforcing catalysts.

Read analysis →
2026-06-10
ENHACMCTBFLYMRVLCAVA

ENHA Soars 50.9% and CMCT Jumps 46.6% as EPS Revisions Drive Gains

Stocks detected by our EPS revision screener on June 2–7 delivered strong gains, led by ENHA (+50.9%) and CMCT (+46.6%). Marvell Technology (+15.1%) benefited from an S&P 500 inclusion announcement that reinforced its upward EPS revision, while CAVA (+12.3%) was further boosted by a UBS upgrade. All five stocks saw forward EPS growth estimates revised sharply higher, triggering price appreciation as the market confirmed the upgrades.

Read analysis →
2026-06-09
ENHACMCTMRVLHUMMAC

EPS Revision Rally: ENHA Soars 38.5%, MRVL +30.2%, CMCT +34.5%

Today's top EPS revision plays delivered significant gains, led by ENHA (+38.5%) and CMCT (+34.5%). Marvell Technology (+30.2%) saw its upward revision amplified by S&P 500 inclusion news, while MAC (+9.3%) and HUM (+10.9%) posted steady gains on pure earnings estimate improvements.

Read analysis →
2026-06-08
MRVLENHATTANHUMMRLN

MRVL Leads EPS Revision Winners with 41% Surge; TTAN, ENHA Follow

Marvell Technology (MRVL) surged 41.0% since a May 28 EPS revision from 44.1% to 50.4% growth, later amplified by S&P 500 inclusion and bullish AI chip demand. ServiceTitan (TTAN) gained 10.9% on a 1.0pp EPS revision followed by a strong earnings beat. Defensive picks ENHA, HUM, and MRLN also rallied on steep EPS growth estimates, reflecting broad market conviction in earnings momentum.

Read analysis →
2026-06-04
MRVLSNOWRDDTHOODSTRL

MRVL Soars 51.9% After EPS Revision; SNOW, RDDT, HOOD, STRL Rally

The EPS revision screener caught upward estimate changes for five stocks on May 26-28, resulting in double-digit gains. MRVL led with a 51.9% surge, fueled by an EPS upgrade and Nvidia CEO's comment. SNOW rose 37.5%, RDDT 27.1%, HOOD 19.2%, and STRL 17.9%, each driven by estimate revisions and supportive market conditions.

Read analysis →
2026-06-03
MRVLSNOWSHAZNETMU

MRVL Leads Tech Surge With 44.8% Gain on EPS Revision and Nvidia Endorsement

MRVL jumped 44.8% after its EPS growth estimate was raised and Nvidia's CEO called it a future trillion-dollar company. SNOW, SHAZ, NET, and MU also posted double-digit gains, all following upward EPS revisions. The moves reflect strong market conviction in AI and data infrastructure earnings momentum.

Read analysis →
2026-06-02
SNOWMRVLARMCLFHBM

SNOW Surges 47% After EPS Revision Leads Software Rally; MRVL, ARM Also Jump

Snowflake (SNOW) jumped 47.0% from $177.60 to $261.14 after its forward EPS growth estimate was raised from 35.0% to 36.0% on May 26, amplified by a broader software sector rally. Marvell (MRVL) gained 39.6% after Nvidia's CEO predicted a $1 trillion valuation, while Arm (ARM) rose 31.4% on AI chip revenue optimism. Basic materials stocks Cleveland-Cliffs (CLF) and Hudbay Minerals (HBM) also surged on EPS upgrades and sector momentum.

Read analysis →
2026-06-01
SNOWARMAPPHBMNET

SNOW Leads Surge After EPS Revision: +57.8%; APP, ARM, HBM, NET Also Rally

Snowflake (SNOW) soared 57.8% after an upward EPS revision from 35.0% to 36.0% on May 26, leading a broad software rally. Other top gainers include Arm Holdings (ARM) +33.4%, AppLovin (APP) +27.4%, Hudbay Minerals (HBM) +25.4%, and Cloudflare (NET) +25.3%, each driven by EPS estimate upgrades detected by our screener. The moves highlight strong momentum in technology and basic materials sectors.

Read analysis →
2026-05-28
DPROSUUNBTDRULCCKULR

Small-Cap Tech Stocks Surge as Analysts Raise EPS Growth Targets

Analysts upgraded EPS forecasts for DPRO and BTDR days before their rallies, validating bullish bets with strong forward earnings growth. ULCC saw the sharpest estimate revision at 119.5% EPS growth next year. These moves show that even small-cap stocks with rising earnings projections can attract market-beating momentum well ahead of actual results.

Read analysis →